AC-102, also known as fluoroharmane, is a drug candidate being developed by the German company AudioCure Pharma for the treatment of acute sensorineural hearing loss (sudden hearing loss), acoustic trauma, and potentially various inner ear disorders.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.